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Background: Human myxovirus resistance protein A (MxA) is an antiviral dynamin-related GTPase.
Results: Dimerization of MxA via a GTPase domain interface is required for GTP hydrolysis and antiviral activity.
Conclusion: GTP binding allows GTPase domain dimerization and membrane-associated assembly of MxA, but it is not
sufficient to induce a sustained antiviral effect.
Significance: New mechanistic insights into the antiviral action of MxA are provided.
Myxovirus resistance (Mx)GTPases are inducedby interferon
and inhibit multiple viruses, including influenza and human
immunodeficiency viruses. They have the characteristic domain
architecture of dynamin-related proteins with an N-terminal
GTPase (G) domain, a bundle signaling element, and a C-termi-
nal stalk responsible for self-assembly and effector functions.
Human MxA (also called MX1) is expressed in the cytoplasm
and is partly associated with membranes of the smooth endo-
plasmic reticulum. It shows a protein concentration-dependent
increase inGTPase activity, indicating regulationofGTPhydro-
lysis via G domain dimerization. Here, we characterized a panel
of G domain mutants in MxA to clarify the role of GTP binding
and the importance of the G domain interface for the catalytic
and antiviral function ofMxA.Residues in the catalytic center of
MxA and the nucleotide itself were essential for G domain
dimerization and catalytic activation. In pulldown experiments,
MxA recognized Thogoto virus nucleocapsid proteins indepen-
dently of nucleotide binding. However, both nucleotide binding
and hydrolysis were required for the antiviral activity against
Thogoto, influenza, and La Crosse viruses. We further demon-
strate that GTP binding facilitates formation of stable MxA
assemblies associated with endoplasmic reticulummembranes,
whereas nucleotide hydrolysis promotes dynamic redistribu-
tion ofMxA from cellularmembranes to viral targets. Our study
highlights the role of nucleotide binding and hydrolysis for the
intracellular dynamics of MxA during its antiviral action.
The myxovirus resistance (Mx)6 proteins are key mediators
of the interferon-induced innate immune response in verte-
brates (1, 2). In humans, twoMxhomologs (MxAandMxB, also
called MX1 and MX2, respectively) mediate antiviral activity
against a broad range of viruses. MxA shows antiviral activity
against several RNA virus families, including orthomyxo-,
paramyxo-, bunya-, picorna-, rhabdo-, toga-, and reoviruses
(3). MxA also restricts DNA viruses, like African swine fever
virus and hepatitis B virus, at the transcriptional level (4, 5).
MxB, in contrast, has recently been shown to be a potent inhib-
itor of HIV and additional lentiviruses (6–9).
Similar to other dynamin superfamily members, MxA binds
to negatively charged membranes and forms ring-like oligo-
mers that tubulate liposomes (10–12). In noninfected cells,
MxA localizes to membranes of the smooth ER (10, 13). Upon
viral infection with La Crosse bunyavirus (LACV), MxA trans-
locates to perinuclear structures containing the viral nucleo-
protein (NP) (14). An interaction ofMx proteins with viral NPs
or ribonucleoprotein complexes was demonstrated for influ-
enza A virus (FLUAV), Thogoto virus (THOV), and LACV
(15–17).
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Mxproteins have a three domain architecture comprising an
N-terminal G domain, an antiparallel three-helical bundle
called the bundle signaling element (BSE), and an antiparallel
four-helical bundle called the stalk (Fig. 1,A andB) (18, 19). The
globular G domain binds and hydrolyzes GTP and is located at
the opposite site of the extended stalk in the elongated MxA
monomer. Between the two domains, the BSE is thought to act
as a mediator of conformational coupling between the G
domain and stalk (20). The stalk mediates ring formation by
assembling in a zigzag fashion via three distinct interfaces (18,
19). It also mediates recognition of viral structures and mem-
brane surfaces via the 43 amino acid loop 4 (L4) that extends
from the distal end of the stalk (12, 21, 22).
The G domain is the most highly conserved region in
dynamin superfamily members, with 40% sequence identity
between dynamin and MxA (23). Dynamin-like GTPases are
characterized by a low basal GTPase activity, which is greatly
stimulated byGTP-dependent dimerization of their G domains
(24). Dimerization in dynamin and the dynamin-1-like protein
(DNM1L) is mediated via a highly conserved interface across
the nucleotide-binding site, the so-called G interface (25, 26),
that was also recently described for MxA (20). We previously
proposed that MxA oligomerizes into rings around viral target
structures (27) as observed for MxA rings assembling around
lipid tubes (12). The G domains dimerize across adjacent rings
thereby mediating inter-ring contacts via the G interface (18).
Similarly,Gdomains in dynamin are thought to dimerize across
helical turns formed around lipid tubes (28). Formation of this
G interface activates GTP hydrolysis by stabilizing the flexible
switch regions containing residues crucial for catalysis. GTP
hydrolysis then triggers a large scale conformationalmovement
of the adjacent BSE, as shown for dynamin and MxA (20, 28),
that may act as a power stroke required for the constriction of
the rings or helices. However, the exact role and function of
GTP binding and hydrolysis for the antiviral activity ofMx pro-
teins remain unclear.
Based on the crystal structure of the dynamin 1 G domain
dimer in the presence of a transition state mimic (25) and pre-
vious functional experiments (18), we performed a systematic
biochemical characterization of several classical and novel
MxA mutants in the G domain to explore the mechanism of
nucleotide binding and hydrolysis in MxA. We found that cat-
alytic residues in the G interface and the nucleotide itself are
involved in G domain dimerization and GTP hydrolysis. Fur-
thermore, we used these mutants in cell-based assays to dissect
the role of nucleotide binding and hydrolysis for the antiviral
function of MxA.
EXPERIMENTAL PROCEDURES
Site-directed Mutagenesis—Expression constructs of MxA
were described previously (18). Site-directed mutagenesis was
carried out using the QuikChange mutagenesis kit (Stratagene,
La Jolla, CA).
Protein Expression and Purification—Human MxA (ExPASy
accession P20591) and the indicatedmutants were expressed as
N-terminal His6 fusions from a pET28 plasmid followed by a
PreScissionTM cleavage site in the Escherichia coli BL21 (DE3)
Rosetta strain (Novagen) (19). Bacterial cultures were grown in
TB medium at 37 °C. At an A6000.4, cultures were cooled to
18 °C, and protein expression was induced by the addition of 40
M isopropyl-D-thiogalactopyranoside. Following centrifuga-
tion, bacterial pellets were resuspended in ice-cold 50 mM
HEPES (pH 7.5), 800 mMNaCl, 30 mM imidazole, 5 mMMgCl2,
1 M DNase I, 2.5 mM -mercaptoethanol (-ME), 500 M
Pefabloc SC (Roth) and lysed in a microfluidizer (Microfluid-
ics). A soluble cell extract was prepared by ultracentrifugation
at 40,000 g for 45min at 4 °C. After filtration, it was applied to
a Ni2-nitrilotriacetic acid column (GE Healthcare) equili-
brated with 50 mM HEPES (pH 7.5), 400 mM NaCl, 30 mM im-
idazole, 5 mM MgCl2, 2.5 mM -ME. The column was exten-
sively washed with 20mMHEPES (pH 7.5), 800mMNaCl, 5mM
MgCl2, 45mM imidazole, 2.5 mM -ME, 1mMATP, 10mMKCl
and afterwards with 20 mM HEPES (pH 7.5), 400 mM NaCl, 5
mMMgCl2, 45 mM imidazole, 2.5 mM -ME. Following protein
elution by 20mMHEPES (pH 7.5), 400mMNaCl, 300mM imid-
azole, 5 mM MgCl2, 2.5 mM -ME, the protein was incubated
overnight at 4 °C in the presence of 250 g of GST-tagged Pre-
Scission protease to cleave theN-terminalHis6 tag. The cleaved
protein was concentrated and applied to a Superdex 200 16/60
(GE Healthcare) gel filtration column equilibrated with 20 mM
HEPES (pH 7.5), 500 mM NaCl, 2 mM MgCl2, 2 mM DTT. Pre-
Scission protease was removed using a GST column. Fractions
containing MxA were pooled, concentrated, and frozen in
small aliquots.
Nucleotide Binding Studies—Nucleotide dissociation con-
stants were determined at 8 °C on a VP-isothermal titration
calorimetry (VP-ITC) system (MicroCalTM, GE Healthcare). 1
mM nucleotide in ITC Buffer (50 mM HEPES (pH 7.5), 150 mM
NaCl, 5 mM MgCl2, 5 mM KCl) was titrated in 8-l steps into a
reaction chamber containing 50 M MxAM527D (or the indi-
cated M527D mutants) in the same buffer. For the K83A
mutant, an iTC200 (Microcal) was used with 200 M protein
and 4 mM guanosine 5-O-[-thio]triphosphate (GTPS). The
resulting heat change upon injection was integrated over a time
range of 240 s, and the obtained values were fitted to a standard
single-site binding model using Origin.
Nucleotide Hydrolysis Assay—GTPase activities of human
MxA mutants were determined at 37 °C in 50 mM HEPES
(pH 7.5), 150 mM NaCl, 5 mM MgCl2, 5 mM KCl. Saturating
concentrations of GTP or xanthosine 5-triphosphate (XTP) (1
mM) were used for each reaction. Reactions were initiated by
the addition of protein to the final reaction solution. For the het-
eromeric stimulation reactions, the concentration of MxAM527D
was kept constant at 2.5 M, and increasing concentrations of
the indicated MxA mutants were added. At different time
points, reaction aliquots were 20-fold diluted in GTPase buffer
(50mMHEPES (pH 7.5), 150mMNaCl, 5mMMgCl2, 5mMKCl)
and quickly transferred into liquid nitrogen. Separation of dif-
ferent nucleotides was achieved on a reversed phase HPLC sys-
tem using a Hypersil ODS-2 C18 column. Nucleotide peaks
were detected by measuring adsorption at 254 nm and com-
pared with standard nucleotide samples. GTP and hydrolysis
product GDP in the samples were quantified by integration of
the corresponding absorption peaks. Rates derived from a lin-
ear fit to the initial rate of the reaction (40%GTP hydrolyzed)
were plotted against the protein concentrations, and the kobs
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values were calculated. For data analysis, the program GraFit5
(Erithacus Software) was used.
Analytical Gel Filtration—The MxA mutants were analyzed
using an FPLC Akta purifier (GE Healthcare) equipped with a
Superdex 200 10/300 column in the absence or presence of the
indicated nucleotides. The running buffer contained 20 mM
HEPES (pH7.5), 150mMNaCl, 2mMMgCl2 but no nucleotides.
The mutants were preincubated for 15 min with 2 mM GDP/
xanthosine 5-diphosphate (XDP), 2mMAlCl3, and 20mMNaF
at 4 °C in gel filtration buffer. 50 l of a 2 mg/ml protein solu-
tion was subsequently applied to the column. A flow rate of 0.5
ml/min was used. Chromatograms were recorded at a wave-
length of 280 nm.
Homology Modeling—For homology modeling, the fully
automated protein structure homology-modeling server,
accessible via the ExPASy web server, was used (29). Subse-
quently, the calculatedmonomericmodel was superimposed to
the GDP-AlF4-boundGTPase dimer of human dynamin 1 (25)
using PyMOL (30).
Cells and Viruses—HEK-293T, HeLa, and Vero cells were
cultivated in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 5% fetal calf serum, 2mM L-glutamine, pen-
icillin (50 units/ml), and streptomycin (50 g/ml). THOV
strain SiAr126 (31) and LACV (32) were used for the infection
experiments.
Minireplicon Assay—To reconstitute the polymerase activity
of FLUAV, strain A/Vietnam/1203/04 (H5N1) (33), 293T cells
were seeded into 12-well plates and transfected with 10 ng of
pCAGGSexpression plasmids for the viral polymerase subunits
PB2, PB1, andPAaswell as 100 ng ofNP-encoding plasmids. As
a minigenome, 50 ng of plasmids encoding firefly luciferase in
negative sense orientation flanked by 5- and 3-UTRs from
viral segment 8 (pPolI-FFLuc-RT for FLUAV) were co-trans-
fected. 10 ng of pRL-SV40, from which Renilla luciferase is
constitutively expressed, was added to normalize transfection
efficiency. It was shown that expression of the firefly luciferase
reporter gene correlates with the activity of the reconstituted
polymerase complex (34).
For reconstitution of the THOV strain SiAr126minireplicon
system (22), 10 ng of pCAGGS expression plasmids for the viral
polymerase subunits PB2, PB1, and PA as well as 50 ng of NP-
encoding plasmids, 50 ng of plasmids encoding firefly luciferase
in negative-sense orientation flanked by 5- and 3-UTRs from
viral segment 5 (pHH21-vNP-FFLuc for THOV) and 10 ng of
pRL-SV40were co-transfected. To examineMx-mediated inhi-
bition of virus polymerase activities, 300 ng (FLUAV minirep-
licon) and 100 ng (THOV minireplicon) of pCAGGS plasmids
coding for N-terminally FLAG-tagged Mx proteins were co-
transfected, respectively. At 24 h post-transfection, cells were
lysed, and firefly and Renilla luciferase activities in the lysates
were measured using the dual-luciferase reporter assay (Pro-
mega). After normalization of firefly to Renilla luciferase
activity, the empty vector control was set to 100%. Each exper-
iment contained technical duplicates, and all experiments were
performed three times. Statistical analysis was done using the
GraphPad Prism 6 software. For expression control, Western
blots with specific antibodies against FLAG or HA tag (Sigma),
FLUAV NP (Serotec), as well as -actin (Sigma) were
performed.
Co-immunoprecipitation and Immunoblot Analysis—293T
cells were transfected with pCAGGS expression plasmids cod-
ing for MxA (1 g, FLAG-tagged wild type (WT) and mutants)
using the Nanofectin transfection reagent (PPA Laboratories).
24 h post-transfection, cells were infectedwith THOVat amul-
tiplicity of infection of 10. 24 h post-infection, co-immunopre-
cipitation analysis was performed. The cells were lysed in 50
mM Tris (pH 8.0), 150 mM NaCl, 1 mM EDTA, 0.5% Nonidet
P-40 and incubated with anti-FLAG-M2 affinity gel (Sigma) for
2 h at 4 °C. The washed precipitates as well as whole cell lysates
to control protein expression were subjected to standardWest-
ern blot analysis using antibodies against FLAG tag (Sigma),
THOV NP (35), as well as -actin (Sigma).
Immunofluorescence Analysis—To examine the intracellular
localization of MxA G domain mutants, HeLa cells were trans-
fected with FLAG-tagged MxA expression plasmids (50 ng per
24-well) and fixed 24 h post transfection with 3% paraformal-
dehyde. MxA was detected with the monoclonal mouse anti-
body M143 (36) and an Alexa Fluor 488-conjugated donkey
secondary antibody (Invitrogen). Fluorescence staining of syn-
taxin 17was performed using a polyclonal goat anti-syntaxin 17
(13) antibody and an Alexa Fluor 555-conjugated donkey sec-
ondary antibody. Immunofluorescence analyses were per-
formed with a Zeiss Axio Observer.Z1 microscope. For co-lo-
calization studies, a Leica TCSSP2 confocal laser scanning
microscope was used.
To detect LACV nucleoprotein-MxA aggregate formation,
Vero cells were transfectedwith FLAG-taggedMxA expression
plasmids (50 ng per 24-well) for 24 h and then infected with
LACV at a multiplicity of infection of 10 for an additional 20 h.
Subsequently, the cells were prepared and stained forMxApro-
teins and viral antigens by indirect immunofluorescence, as
described previously (14). MxA was detected as described
above and LACV nucleoprotein (N) protein with a polyclonal
rabbit antibody. Alexa Fluor 555- and Alexa Fluor 488-conju-
gated donkey secondary antibodies (Invitrogen) and an Apo-
Tome fluorescencemicroscope (Zeiss) were used for the detec-
tion of the proteins.
RESULTS
Analysis of the GTPase Mechanism of MxA—To gain
insights into the GTPase mechanism of MxA, we modeled
the G domain dimer of MxA based on the structure of the
GDP-AlF4-bound dynamin (Fig. 1C) (25). Most of the resi-
dues in the catalytic center are highly conserved between
MxA and dynamin, for example the G4 loop mediating spec-
ificity for guanine binding (Fig. 1D), suggesting a conserved
catalytic mechanism of these proteins. The modeled dimer
interface was recently confirmed by crystal structures of a
stalkless MxA construct determined in the absence of nucle-
otide, in the presence of GDP or of the nonhydrolyzable GTP
analogue GMP-PCP (20).
For this study, we focused on several positions in or close
to the catalytic center of the G domain (Fig. 1E) as follows:
Lys-83 in the highly conserved phosphate-binding loop (37);
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Thr-103 in the switch I region that is crucial for stabilizing the
transition-state of GTP hydrolysis (38); Asp-250 contacting the
purine base in cis; and Asp-253 stabilizing the G interface by
contacting the purine base of the opposing G domain in trans
(Fig. 1E). To test the contribution of individual positions for GTP
binding andhydrolysis in biochemical assays,weused apreviously
described monomeric stalk mutant of MxA, MxAM527D, and
introduced the respective mutations. MxAM527D cannot
assemble into higher order oligomers (18), shows greater solu-
bility than the WT protein, and can be prepared in high quan-
tities from bacterial lysates without aggregation. Nucleotide
binding to this mutant can reliably be measured by ITC, with-
out considering competing reactions such as higher order
assembly via the stalk domains.
Initially, we determined the nucleotide binding affinities of
MxAM527D. It bound to the slowly hydrolysable GTP analogue
GTPS with an affinity of 15 M (Fig. 2A and “Experimental
Procedures”, Table 1 for a summary of all data), in good agree-
ment with previous measurements using fluorescence analysis
(18). In gel filtration experiments, thismutant eluted as amono-
mer when incubated with GTPS, GDP or in the absence of
nucleotide (Fig. 3A). However, in the presence of GDP-AlF4
that mimics the transition state of GTP hydrolysis, MxAM527D
dimerized, suggesting that trapping of the GTPase transition
state is accompanied by G domain dimerization (Fig. 3A). In
agreement with previous results (18), MxAM527D showed a
robust intrinsic GTPase activity that cooperatively increased
with increasing protein concentrations (Fig. 4A), again indicat-
ing that the formation of a G interface leads to stimulated GTP
hydrolysis.
Lys-83 in MxA is part of the phosphate-binding loop. In
dynamin, the corresponding K44A mutant was originally
designed as a GTP-binding deficient mutant, based on homol-
ogy to the Ras GTPase (39). In dynamin, this mutant is now
widely used to block clathrin-mediated endocytosis (40). Inter-
estingly, recent cryo-EM data showed that the dynamin K44A
mutant can form a super-constricted helix in the presence of
GTP (41). In MxA, K83A was suggested to affect GTP binding
(37). In our ITC assays, however, MxAM527D/K83A still bound
GTPS with a dissociation constant of 39 M, i.e. a slightly
reduced affinity comparedwithMxAM527D (Fig. 2B). Dimeriza-
tion of this mutant in the presence of GDP-AlF4 was greatly
FIGURE 1. Structure and GTPase domain dimerization of MxA. A, domain architecture; B, structure of human MxA (Protein Data Bank code 3SZR). C,
homologymodel of theMxAGTPase domain dimer (residues 69–340) based on the crystal structure of the human dynamin1 GTPase domain-BSE construct in
the GDP-AlF4
-bound state (Protein Data Bank code 2X2E). D, sequence alignment of Mx and dynamin proteins in the G4 loop. Sequences of human MxA
(Swiss-Prot accession P20591), human (hs) MxB (P20592), mouse (mm) Mx1 (P09922), mmMx2 (Q9WVP9), chicken (gg) Mx (Q90597), zebrafish (dr) MxA
(Q8JH68), human dynamin1 (Q05193), human dynamin2 (P50570), human dynamin3 (Q9UQ16), Drosophila melanogaster (dm) dynamin (P27619),
Caenorhabditis elegans (ce) dynamin (Q9U9I9), and Saccharomyces cerevisiae (sc) dynamin-relatedproteinDNM1 (P54861)were alignedandmanually adjusted.
Residueswith a conservation of greater than 70% are color-coded (D and E in red; R, K, andH in blue;N, Q, S, and T in gray; A, L, I, V, F, Y, W, M, and C in green, and
P and G in brown). Asp-250 and Asp-253 are marked with a dot. E, details of the catalytic site. The red ball represents the catalytic water, the green ball a Mg2
ion, and thepurple ball aNa ion. Asp-250 stabilizes thepurinebase in cis, andAsp-253of theneighboringmonomerbinds to it in trans. F, left, scheme showing
the proposed bindingmode of the guanine base by Asp-250 in cis and Asp-253 of the opposingmolecule in trans. Right, xanthosine base-binding by Asn-250
and envisaged binding mode of Asn-253. Hydrogen bonds are depicted as dashed lines.
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FIGURE 2.Nucleotide binding analysis. 1mM solutions of the indicated nucleotidewere titrated stepwise into 50M solutions of the indicatedMxAmutants
at 8 °C in an ITC device. Resulting heat changes were integrated, and the obtained values were fitted to a quadratic binding equation. The following KD values
were derived from the fittings. A, M527D for GTPS: KD 	 15 
 1 M, n 	 0.92 
 0.02. B, M527D/K83A for GTPS: KD 	 39 
 6 M, n 	 0.42 
 0.03. C,
M527D/T103A for GTPS: KD	 28
 2M, n	 0.81
 0.02.D,M527D/D250N for XTPS: KD	 7.8
 0.5M, n	 0.82
 0.01. E,M527D/D253N for GTPS: KD	
9
 1M, n	 0.73
 0.01 and F,M527D/D250N/D253N for XTPS: KD	 5.6
 0.4M, n	 0.87
 0.01. GTPS () and XTPS (E). Because of the reduced heat
signal upon nucleotide binding, higher protein and ligand concentrations were used for the T103A and K83A mutants. For K83A, this resulted in increased
protein precipitation that may explain the lowered binding number.
TABLE 1
Summary of the biochemical and antiviral features of the examinedmutants
* Experiments were performed with the monomeric M527D mutant.
# Data are at a 20 M protein concentration.
n.d. indicates not determined.
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FIGURE 3. Analytical gel filtration analysis. Upon 15 min of incubation with 2 mM of the indicated nucleotide solutions, 50 l of the indicated MxA
mutants at a concentration of 2mg/ml were applied to an S200 gel filtration column. A,M527Dwith GTPS, GDP-AlF4
, GDP, AlF4
 alone or in the absence
of nucleotides. B, M527D/K83A. C, M527D/T103A. D, M527D/D250N. E, M527D/D253N. F, M527D/D250N/D253N in the absence and presence of the
indicated nucleotides.
FIGURE 4. Analysis of GTPase activities. A, protein concentration-dependent GTPase/XTPase activities of M527D and representative mutants. All
reactions were carried out in the presence of 1 mM nucleotide at 37 °C, and GTP/XTP hydrolysis was monitored by HPLC analysis. The mean kobs was
calculated from two independent experiments for each concentration, with the error bar showing the range of the two data points. M527D (GTP) (ƒ),
M527D/K83A (GTP) (), M527D/T103A (GTP) (), M527D/D250N (XTP) (), M527D/D253N (GTP) (), and M527D/D250N/D253N (XTP) (E). B, GTPase
activity of M527D can be stimulated by monomeric G domain mutants of MxA. 2.5 M M527D was incubated with the indicated concentrations of the
correspondingmutant (see x axis). Themean kobs calculated from two independent experiments is indicated, with the error bar showing the range of the
two data points. M527DM527D/T103A (E), M527DM527D/D250N (), M527DM527D/D253N (). C,mixed GTPase assays, similar as in B, using 37.5
M of each of the indicated M527Dmutants. The mean kobs was calculated from two independent experiments, with the error bar showing the range of
the two data points. When two monomeric G domain mutants were incubated together, their GTPase reactions were mostly additive.
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reduced (Fig. 3B), and nucleotide hydrolysis was completely
blocked for MxAM527D/K83A (Fig. 4A).
The T103A exchange in MxA was considered to block GTP
hydrolysis but not GTP binding (38). The corresponding
Thr-65 in dynamin is located in switch I and was shown to
stabilize the attacking water molecule for GTP hydrolysis via a
main chain interaction (25). Furthermore, the side chain of
Thr-65 coordinates the catalyticMg2 ion. TheT65Amutation
was proposed to affect only GTP hydrolysis (42), although oth-
ers suggested it may reduce nucleotide binding as well (43). In
ITC experiments, MxAM527D/T103A bound GTPS with a
slightly reduced affinity (KD 	 28 M) compared with
MxAM527D, indicating that the T103A exchange did not grossly
affect nucleotide binding (Fig. 2C). However, this mutant did
not dimerize in the presence of GDP-AlF4 (Fig. 3C) and
showed a complete loss of basal and stimulatedGTPase activity
(Fig. 4A), suggesting that it cannot stabilize aGTPase transition
state.
To create a bona fide GTP-binding deficient mutant, we
turned towards an amino acid exchange in the guanine
nucleotide specificity (G4) motif. In the small GTPase Ras
and the signal recognition particle GTPase (44–46), the
mutation of an aspartate to an asparagine in G4 abrogates
GTP binding and allows binding of the related XTP. In
agreement with these observations, also the corresponding
MxA mutant MxAM527D/D250N lost its ability to bind GTPS
but bound XTPS with a dissociation constant of 7.8 M (Fig.
1F, 2D), whereasMxAM527D did not bind toXTPSwith appre-
ciable affinity (Fig. 2A). However, addition of XDP-AlF4 did
not result in dimerization ofMxAM527D/D250N (Fig. 3D), and the
mutant did not show stimulated XTPase activity (Fig. 4A) nor
GTPase activity (data not shown). Thus, not only nucleotide
binding but also the nature of the bound nucleotide itself con-
tributes to dimerization and dimerization-stimulated GTP
hydrolysis.
In dynamin, Asp-211 following the G4 motif mediates
dimerization by contacting the nucleotide in the opposingmol-
ecule via a contact to the guanine base (25). This residue is also
conserved in MxA (Asp-253) and contacts the guanine base
(Fig. 1E) (20). We reasoned that the lack of XTPase reaction in
MxAM527D/D250N mutant might be caused by the inability of
Asp-253 to contact the xanthosine base in trans. To explore this
hypothesis, we sought to restore this putative contact in MxA
by additionally introducing the D253N mutation, which in
principle should be able to form two hydrogen bonds with the
xanthosine base in trans (Fig. 1F). The MxAM527D/D253N
mutant bound GTPS with comparable affinity to MxAM527D
(KD	 9M) (Fig. 2E), but it did not dimerize in the presence of
GDP-AlF4 (Fig. 3E). It also did not display any GTPase activity
(Fig. 4A), indicating an involvement of Asp-253 in dimeriza-
tion-induced catalysis of MxA. The MxAM527D/D250N/D253N
mutant bound with a dissociation constant of 5.6M to XTPS
but not to GTPS (Fig. 2F). However, also for this mutant, we
did not observe XDP-AlF4-induced dimerization (Fig. 3F) and
no stimulated XTPase (Fig. 4A) and GTPase (data not shown)
activity, indicating that the D253N mutation cannot restore a
putative contact to XTP in trans. We speculate that the D250N
mutant binds the xanthosine base with a slightly different
geometry compared with the genuine guanine-base binding
mode. Such a differencemay then affect the overall geometry of
the catalytic site in a way that is not compatible with G domain
dimerization and initiation of nucleotide hydrolysis.
One Intact Catalytic Center Is Sufficient for Nucleotide
Hydrolysis—To further characterize the requirements for for-
mation of the G domain interface, we analyzed the ability of the
differentmutants to stimulate the GTPase activity of theWTG
domain ofmonomericMxAM527D in amixedGTPase assay. For
these experiments, we employed a constant low concentration
of 2.5 M MxAM527D and added increasing amounts of
MxAM527D mutants defective in GTP hydrolysis (T103A),
nucleotide binding (D250N), or G interface formation
(D253N). Strikingly, the monomeric T103Amutant stimulated
the GTPase activity of MxAM527D as efficiently as monomeric
MxAM527D (compare Fig. 4, A with B), whereas the G interface
mutant D253N was a less potent activator, indicating that one
functional GTPase site can be sufficient for the formation of a
functional G interface with a GTP-binding competent mutant.
The GTP-binding deficient D250Nmutant showed only minor
GTPase activation of MxAM527D, indicating that the loss of
nucleotide binding (D250N) in one molecule interferes with
dimerization-induced GTP hydrolysis. Interestingly, GTP hy-
drolysis by the monomeric T103A, D250N, or D253Nmutants
could not be restored by any of the other defectivemutants (Fig.
4C), indicating that defects in both partner molecules com-
pletely abrogate GTPase activity.
Nucleotide Binding andHydrolysis Are Required for Antiviral
Function of MxA—Equipped with a biochemically validated set
of G domain mutants, we explored the role of nucleotide bind-
ing and hydrolysis for the antiviral activity of MxA. Initially, we
assessed inhibition of the polymerase complex of THOV, a
FLUAV-like orthomyxovirus, that shows high sensitivity to the
antiviral effect of MxA (47, 48). We used a minireplicon
reporter assay to study the polymerase activity of THOV (22).
Co-expression of the viral polymerase subunits and the viral
NP, together with an artificial RNA minigenome encoding the
firefly luciferase reporter gene, reconstitutes viral ribonucleo-
protein complexes that are active in transcription and replica-
tion of the minigenome. Additional expression of WT MxA
suppressed viral polymerase activity to 2% (Fig. 5A). However,
the introduction of the previously characterized point muta-
tions in the G domain all led to a partial or complete loss of the
antiviral function (Fig. 5A and Table 1) indicating that the full
cycle of GTP binding, hydrolysis, andG domain dimerization is
crucial for the antiviral effect.
A direct and robust interaction of MxA with the NP of
THOV, the major constituent of the viral nucleocapsids, has
previously been demonstrated (16). It involves loop L4 at the tip
of the stalk that directly interacts with the viral NP (22). To test
the influence of our G domain mutations on viral target inter-
action, cells expressing the respective FLAG-tagged MxA
mutants were infected with THOV, and viral NP was co-pre-
cipitated from the cell lysates using a FLAG-specific antibody.
The viral NP was co-precipitated by WT MxA, but not by an
MxA mutant with a deletion of loop L4 (L4) that lacks the
putative NP interaction site (Fig. 5B, lane 9) (22). Interestingly,
in pulldown experiments, theGdomainmutantsK83A,T103A,
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D250N, D253N, and D250N/D253N efficiently precipitated
THOVNP from the infected cells (Fig. 5B). V185Ywas included
in the analysis because this exchange was recently shown to
disrupt formation of the G interface (20). This mutant also
bound efficiently to the NP (Fig. 5B, lane 5), but it showed
severely reduced antiviral activity (Fig. 5A). These results indi-
cate that nucleotide binding and hydrolysis of MxA are not
required for THOVRNPbinding but are essential for executing
the subsequent antiviral effect against THOV.
Next, we assessed inhibition of a highly pathogenic H5N1
influenzaAvirus (49) using a previously describedminireplicon
reporter assay for FLUAV (33). In these assays,WTMxA inhib-
ited viral replication by 80% (Fig. 6A). However, all tested G
domain mutations completely abrogated antiviral activity. To
further explore the effect of these mutants, we co-expressed
some of them withWTMxA, expecting a stimulatory effect, as
detected for the stimulation of the GTPase activity in Fig. 4B.
When co-expressed even at low concentrations, the G domain
mutants interfered with the antiviral activity of WT MxA in a
dominant-negative fashion (Fig. 6B). However, the oligomeri-
zation-defective mutant MxAM527D that was shown to be anti-
virally inactive (18) did not affect the antiviral activity of WT
MxA in these co-expression experiments, presumably because
it was not incorporated intoWTMxA oligomers. This suggests
that incorporation of GTP-binding or GTPase-deficient MxA
molecules into a hetero-oligomeric complex can hamper the
antiviral activity of WTMxA.
Role of Nucleotide Binding and Hydrolysis in Formation of
Cytoplasmic MxA Assemblies—To further study the conse-
quences of the lack of GTP binding and hydrolysis, we analyzed
the intracellular distribution of the MxA mutants. For this,
HeLa cells were transfected with the various MxA constructs,
and their localization was analyzed by immunofluorescence
using anMxA-specificmonoclonal antibody (36). In agreement
with previous data, WTMxA showed a diffuse cytosolic stain-
ing with some punctate structures (Fig. 7). These structures
co-localized with syntaxin 17, a marker of the smooth ER, indi-
cating an association of WT MxA with this membrane com-
partment (Fig. 8), as reported previously (13). In contrast, the
GTPase-deficient mutants, K83A, T103A, V185Y, and D253N,
that showed GTP binding but not hydrolysis, aggregated in
large cytosolic clusters (Fig. 7). These clusters also co-localized
with the smooth ER marker syntaxin 17 (Fig. 8). However,
MxAD250N, the only mutant defective in GTP binding, showed
a cytosolic distribution without punctate aggregates (Fig. 7),
pointing to a role of GTP binding for the formation of intracel-
FIGURE 5. G domain mutants interact with the viral NP. A, 293T cells were co-transfected with expression plasmids for the THOV minireplicon system,
consisting of the viral polymerase subunits (10 ng each), NP (50 ng), and the pPolI-FF-Lucminigenome encoding firefly luciferase (50 ng) as well as expression
plasmids for MxA or MxAmutants (100 ng) for 24 h. Firefly luciferase activity determined in the cell lysates was normalized to the activity of Renilla luciferase
encoded by the co-transfected pRL-SV40 plasmid (10 ng). The activity in the absence of MxA, empty vector control, was set to 100%. Results are presented as
meansof technical duplicates of three independent experiments. Protein expressionof FLAG-taggedMx, viral NP, and-actinwasdeterminedbyWesternblot
analysis. B, co-precipitation of viral NP with MxA. 293T cells were transfected with FLAG-tagged MxA constructs and infected with THOV (10 multiplicities of
infection). At 24 h post-infection, the cell lysateswere subjected to FLAG-specific immunoprecipitation (IP). FLAG-MxA and co-precipitated THOV-NP aswell as
whole cell lysates (WCL) were analyzed by Western blot. Results of one experiment that is representative for three individual experiments are shown.
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lular MxA assemblies that are associated with syntaxin 17-pos-
itive membranes. This was supported by the observation that
introduction of the D250N mutation into GTPase-deficient
MxA mutants also led to an even cytoplasmic distribution, as
exemplified for MxAT103A, MxAV185Y, and MxAD253N versus
the respective double mutants (Figs. 7 and 8).
In a further set of experiments, we tested the intracellular
redistribution of the MxA mutants induced by LACV infec-
tion. LACV replicates in the cytoplasm, and the viral nucleo-
protein (N) accumulates in the Golgi area at a late phase of the
replication cycle (Fig. 9, vector, white arrow). However, during
the process of MxA-mediated restriction of LACV replication,
MxA associates with newly synthesized viral N protein and
sequesters it into large perinuclear MxA-N assemblies that
are a readout for the antiviral effect (14). Accordingly,WTMxA
formed the characteristic perinuclear assemblies with the viral
N upon infection with LACV (Fig. 9, wt, yellow arrow). In
contrast, the GTPase-deficient mutants, MxAT103A and
MxAD253N, that spontaneously aggregated into MxA assem-
blies did not show obvious redistribution upon viral infection
and thus did not limit viral replication, as indicated by the local-
ization of N to the Golgi area (Fig. 9, white arrows). Interest-
ingly, the GTP-binding deficient mutants MxAD250N and
MxAD250N/D253N showed a diffuse cytoplasmic staining pattern
FIGURE 6. Functional GTPase is crucial for antiviral activity. A, 293T cells were co-transfected with expression plasmids for the FLUAVminireplicon system
of VN/04, consisting of the viral polymerase subunits (10 ng each), NP (100 ng), and the pPolI-FF-Lucminigenome encoding firefly luciferase under the control
of the viral promoter (50 ng) as well as expression plasmids for MxA or MxA mutants (300 ng). After 24 h, firefly luciferase activity was determined in the cell
lysates and normalized to the activity of Renilla luciferase encoded by the co-transfected pRL-SV40 plasmid (10 ng). The activity in the absence of MxA, empty
vector control, was set to 100%. Protein expressionof FLAG-taggedMxA, viral NP, and-actinweredeterminedbyWesternblot analysis.B,dominant-negative
effect of MxA mutants on WT MxA activity. HA-tagged WT MxA (300 ng) was co-transfected with the components of the VN/04 minireplicon system as
described for A and increasing amounts (50, 100, and 200 ng) of the indicated FLAG-tagged MxA mutants. Results are presented as means of technical
duplicates of three independent experiments.
FIGURE 7. Intracellular distribution of MxA G domainmutants. HeLa cells were transfected with expression plasmids for WT MxA or MxAmutants (50 ng).
At 24 h post-transfection, cells were fixed and stained with a specific antibody against MxA. Results are representative for three individual experiments.
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and did not form a complex with viral N (Fig. 9). Taken
together, these results suggest that MxA mutants defective in
GTP binding, G domain dimerization, and GTP hydrolysis lose
antiviral activity against orthomyxoviruses and LACV.
G255E and V268M Are Natural Genetic Variations in the
Putative G Interface—Human MxA is highly conserved with
only few allelic variations in the human population. A recent
analysis of genomic DNA from healthy individuals identified
some rare variants in theMX1 gene. Two of them are located in
the G interface and lead to an exchange of glycine to glutamic
acid at position 255 and valine to methionine at position 268,
respectively (Fig. 10A) (50).We testedwhether thesemutations
affect catalysis and function of MxA. Interestingly, the
MxAM527D/V268M and MxAM527D/G255E mutants displayed
reduced or a complete loss of GDP-AlF4-induced dimerization
(Fig. 10, B and C). Correspondingly, the mutations led to a
reduction and a complete loss of GTPase activation, respec-
tively (Fig. 10D), suggesting that they decrease the capacity to
form a properG interface to different extents. Furthermore, the
G255E mutation completely abolished the antiviral activity of
MxA in the FLUAV minireplicon assay and led to cytoplasmic
aggregates when expressed in HeLa cells. The MxAV268M
mutant showed a slightly but significantly reduced antiviral
activity (Fig. 10E) and a diffuse cytosolic staining, including
small punctate assemblies that were markedly different from
the few large aggregates formed byMxAG255E. The pattern was
rather reminiscent of that observed for WT MxA (Figs. 7 and
10F).
DISCUSSION
A prominent feature of the dynamin superfamily proteins is
their concentration-dependent increase ofGTPase activity. For
dynamin and dynamin-related proteins, such as MxA or the
guanylate-binding protein 1, GTPase activation is mediated by
nucleotide-dependent dimerization of the G domains via the G
interface, which induces rearrangements of catalytic residues in
the active site (20, 25, 51). The GTPase activity of dynamin and
many dynamin-related proteins has been implicated in the
nucleotide-dependent remodeling of cellular membranes.
However, the exact function of the GTPase for the antiviral
action of MxA has remained unclear. Current knowledge indi-
cates that the antiviral activity of MxA is dependent on GTP
hydrolysis (37, 38) and oligomerization via the stalk (18, 19, 52,
53). In this study, we used a panel of G domain mutants to
demonstrate that nucleotide binding and formation of the G
interface are critical for the intracellular localization and the
antiviral function of MxA.
Structural analysis indicates that the G domain dimer of
dynamin and MxA is formed by direct contacts between the
two switch regions and the trans stabilizing loop (20, 25). Fur-
thermore, Asp-253 from the G4 loop stabilizes this interaction
by contacting the guanine base of the opposite G domain in
trans. The nucleotide base, in turn, is bound in cis by the highly
conservedAsp-250 in theG4 loop that is crucial for nucleotide-
binding specificity. Accordingly, theD250Nmutation switched
the nucleotide binding preference from guanosine to xan-
thosine triphosphates, as described previously for Ras-like
GTPases and the signal recognition particle (46, 54, 55).
MxAK83A was previously annotated as a nucleotide-binding
deficient mutant (37). Surprisingly, we found that it can still
bind to nucleotides, albeit with reduced affinity; instead, it is
deficient for GTP hydrolysis and essentially behaves as
MxAT103A (38) in all assays that we tested. These two mutants
FIGURE 8. Co-localization study of MxA G domain mutants with syntaxin 17. HeLa cells were transfected with expression plasmids for WT MxA or MxA
mutants (50 ng). At 24 hpost-transfection, cellswere fixed and stainedwith specific antibodies againstMxA (green) and syntaxin 17 (red). Immunofluorescence
analysis was performed using a confocal laser scanning microscope.
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were previously used to assess the effects of GTP binding and
hydrolysis for the antiviral effect of MxA against FLUAV and
vesicular stomatitis virus (37, 38) and recently of theMxApara-
log MxB against HIV-1 (7, 8). In light of our biochemical anal-
ysis, some of the interpretations previously drawn fromanalysis
of the K83A mutant may have to be revisited or experiments
repeated using, for example, the nucleotide-binding deficient
D250N mutant.
In agreement with the data from Rennie et al. (20), we found
thatmonomericMxAM527D (18) dimerized in solution via theG
domain in the presence of the transition state analogue GDP-
AlF4. However, MxAM527D did not dimerize in the presence of
GTPS, GDP, and AlF4 alone or GMP-PCP (data not shown),
indicating that formation of the G interface is a low affinity,
transient process. Accordingly, MxA variants with defective
guanine binding in cis or in trans, like MxAD250N and
MxAD253N, lost GDP-AlF4-induced dimerization via the G
interface, as recently described for the V185Y mutation at the
center of the G interface (20). We speculate that in native
assemblies of WT MxA that oligomerize via the stalk region
(18, 19), G interfaces are stabilized by the simultaneous forma-
tion of multiple interactions within the large oligomers.
Mixed GTPase assays demonstrated that the G domain
mutants, despite being defective in their own hydrolysis, could
still effectively stimulate the GTPase activity of an opposing
WT G domain. The T103A mutant that is deficient in GTP
hydrolysis stimulated the GTPase of an opposing WT G
domain to a similar extent asWTMxA. In contrast, loss of GTP
binding as exemplified by the D250N mutant greatly reduced
GTPase stimulation. These data demonstrate a crucial role of
GTP binding for the induction of a G domain dimerization-
competent conformation in MxA. Our analysis of the
MxAT103A mutant further indicates that the GTPase activity
is not coupled between two interacting G domains and that
FIGURE 9. Complex formation of MxAwith the LACV nucleoprotein. Vero cells were transfected with the indicatedMxA expression constructs (50 ng) and
infectedwith LACV. At 18hpost-infection, cellswere fixed, and immunofluorescence analysiswasperformedusing specific antibodies againstMxA (green) and
LACV-N (red). Themock panel shows overlay images of transfected and mock-infected cells. Thewhite arrows indicate accumulation of N protein in the Golgi
area that is devoid of an MxA signal. In WT MxA-expressing cells, yellow arrows indicate formation of ER resident MxA-N assemblies.
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each G domain can independently hydrolyze GTP upon
dimerization.
All G domain mutants in the context of the oligomerization-
competentWTMxA protein lost their antiviral activity against
THOV and FLUAV. In addition, the formation of MxA assem-
blies with the viral N protein in LACV-infected cells, a measure
of an MxA-mediated block of viral replication (14), was not
observed for ourGdomainmutants. Interestingly, all G domain
mutants acted in a dominant-negative fashion on the antiviral
effect of WT MxA. This supports a model wherein the incor-
poration of a few GTP-binding or GTPase-deficient mutants
into WT MxA oligomers impedes MxA activity that requires
formation of MxA oligomers around viral nucleocapsids, coor-
dinated GTP hydrolysis, and structural transformations in the
MxA oligomers. Surprisingly, the binding of the viral NP in
THOV-infected cells was not affected by G domain mutations
in pulldown experiments, indicating that the recognition of the
viral target by MxA is independent of the GTPase cycle.
It has been observed in previous studies that nucleotide bind-
ing promotes oligomerization of MxA (11, 19). This can be
explained by the additional nucleotide-driven association
between G domains stabilizing the MxA oligomer. Accord-
ingly,WTMxA that may cycle between GTP- and GDP-bound
states showed a typical dispersed cytoplasmic localization with
a few small assemblies that co-localized with markers of the
smooth ER (13, 52). When analyzing the intracellular localiza-
FIGURE 10. Effects of MxA polymorphisms in the G interface. A, homology model of the MxA GTPase domain dimer as in Fig. 1C. Interface residues are
depicted as balls: Val-185 (purple), Gly-255 (red), and Val-268 (green) with the superscript letter indicating monomer A or B, respectively. B and C, analytical gel
filtrationanalysis ofM527D/G255EandM527D/V268Mas inFig. 3.D,protein concentration-dependentGTPaseactivitiesofM527D (E),M527D/V268M(), and
M527D/G255E (‚) as in Fig. 4A. E, FLUAV-minireplicon system of VN/04, as described in Fig. 6A. Significancewas calculatedwith Student’s t test (n	 3). **, p	
0.0058; ***, p	 0.0002. F, intracellular distribution of G255E and V268M in HeLa cells, as in Fig. 7.
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tion of the G domainmutants, striking differences to the distri-
bution of WT MxA became apparent. The nucleotide-binding
competent but hydrolysis-defective K83A, T103A, and D253A
mutants formed few large intracellular aggregates that co-local-
ized with the smooth ERmarker syntaxin 17 (56). However, the
nucleotide-binding deficientD250Nmutantwas uniformly dis-
persed throughout the cytoplasm of the transfected cells. To
exclude the possibility that the formation of the large MxA
granules is a consequence of the structural disturbance of the
mutant proteins rather than a function of the nucleotide bind-
ing status of MxA, we combined the G domain mutants that
prevent hydrolysis with the D250N mutant that prevents GTP
binding. Intriguingly, the double mutants showed the same dif-
fuse distribution as observed previously for the nucleotide-
binding deficientmutant, indicating that constantGTPbinding
stabilizes membrane-associated MxA aggregates. GTP hydro-
lysis and possibly the release of the nucleotides is thus a prereq-
uisite for dissociating these assemblies. As suggested previously
(18, 27), dimeric or tetrameric forms of MxAmight be released
from these membrane-associated stores to initiate the antiviral
action.
The human MX1 gene is highly conserved and only a few
single nucleotide polymorphisms are described in the human
population (57). However, a recent study analyzing variations
in theMxA genes of 267 healthy individuals identified two rare
nucleotide changes that result in amino acid exchanges at posi-
tions 255 and 268 (50). Based on the structural models of the G
domain dimer, these exchanges localize to the G interface and
might thus influence its formation or function. Interestingly,
the V268M substitution showed diminished GTP hydrolysis
but only a slightly reduced antiviral activity. ThisMxAvariation
was found homozygotic in a single individual (50). However,
the G255E exchange completely abolished GTPase and antivi-
ral activity of MxA in our analysis. The close proximity of Gly-
255 to Asp-250 and Asp-253 raises the possibility that the
G255E exchange also interferes with the formation of the G
interface. The rare occurrence of polymorphic changes in theG
domain of MxA, like the G255E exchange that was found only
heterozygotic in two individuals (50), underlines the impor-
tance of this structural element for the antiviral function of
MxA and suggests a central role of MxA for the antiviral host
defense in humans. It would be interesting to study whether
such polymorphisms are enriched in patients suffering from
severe influenza as has been described recently for IFITM3,
another IFN-induced antiviral restriction factor against influ-
enza A virus (58).
In summary, our data suggest a dual role for the GTPase
activity inMxA function. Upon induction by interferons, newly
synthesized MxA is initially deposited close to ER membranes.
Following viral infection, GTP hydrolysis is required for the
dynamic redistribution of MxA from these depots to the viral
ribonucleoproteins or nucleocapsids, the target of MxA action.
In the absence of GTPase activity, this release is prevented and
MxA, most likely in its GTP-bound state, stays inactive in the
membrane-associated deposits. The regular oligomerization of
MxA molecules into ring-like structures around the viral
nucleocapsids allowsmultiple contacts with viral NPs, themain
component of the nucleocapsids. GTP bindingmay not be nec-
essary for the initial recognition of viral targets, but it might
stabilize the MxA-NP complex. How nucleotide hydrolysis is
additionally required for inactivation of the viral target struc-
ture or for the recycling of nucleocapsid-boundMxA is amatter
of future investigations.
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